Search 

one of the biggest pharmaceutics in china.

CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, 5 late-stage candidates are at pivotal trials. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone's vision is to become globally recognized as a leading Chinese biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.

CTS Capital was founded in 2017. As a private equity firm, CTS Capital focuses on investment opportunities in the biotechnology and healthcare services industries. CTS Capital is managed by a team of professionals with deep industry knowledge, extensive experiences in private equity and global strategic insights. Driven by our team’s business acumen and investment expertise, CTS Capital has made investments in companies at the cutting edge of the biotechnology and healthcare industries, including innovative drugs, medical devices, diagnostics, gene technology, digital health and AI in healthcare，etc.
We employ a research-driven investment approach and collaborate closely with our companies to build lasting and impactful businesses in the life sciences and healthcare industries. We are committed to working in close partnership with the top innovative pharmaceutical, biotech and medical technology companies to promote biotechnology innovation and healthcare transformation in China.

投资医疗一级市场

Curon biopharma is a clinical stage biopharmaceutical company focused on next generation anti-cancer therapies

专注医疗投资

Oncology Big Data company headquartered in Beijing. Chinese name 神州医疗 or Digital Health China. US branch in Boston.

biotech focusing on world leading r&d to solve unmet medical needs

大博医疗科技股份有限公司是一家A股上市的综合性医用高值耗材公司。立足于骨科产品的行业优势地位，现已是国内最具成长性的医用高值耗材企业之一。

Duality Biologics is a China biotech company focusing on the discovery, development and commercialization of new modality biologics to provide solutions to unmet medical needs for grievous diseases in Great China area. Backed by proprietary new modality platform ensuring fast biological validation and development, Duality Biologics has been building a combined pipeline of First-in-class and Best-in-class. Currently, Duality seeks for licensing-in opportunities in broad disease areas especially oncology and autoimmune diseases